Spruce Biosciences Inc Forecast, price target & analysts
Spruce Biosciences Inc Target price 2025 - Analyst rating & recommendation
Spruce Biosciences Inc Classifications & Recommendation:
Spruce Biosciences Inc Price Target
| Target Price | $1.50 |
| Price | $0.29 |
| Potential |
412.47%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Spruce Biosciences Inc price target 2026.
The average Spruce Biosciences Inc target price is $1.50.
This is
412.47%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Spruce Biosciences Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Spruce Biosciences Inc stock has an average upside potential 2026 of
412.47%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.09 | 5.09 |
| 49.52% | ||
| Net Margin | -507.55% | -770.31% |
| 51.77% |
5 Analysts have issued a sales forecast Spruce Biosciences Inc 2024 . The average Spruce Biosciences Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Spruce Biosciences Inc 2024 . The average Spruce Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.24 | -0.95 |
| 36.73% | 23.39% | |
| P/E | negative | |
| EV/Sales | negative |
1 Analysts have issued a Spruce Biosciences Inc forecast for earnings per share. The average Spruce Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Spruce Biosciences Inc...
Current Spruce Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 19 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 16 2024 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Dec 12 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 12 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 19 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
